81 results
-
List item
National expert: Caridad Pontes, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 41.45 KB | PDF
- Curriculum Vitae - 77.28 KB | PDF
-
List item
Referral: Protium
pantoprazole, associated names: Anagastra, Apton, Controloc, Eupantol, Inipomp, Pantec, Pantecta, Pantipp, Panto-Byk-20 / 40 / IV, Pantoc, Pantoloc, PantoLomberg, Pantopan, Pantorc, Pantozol, Peptazol, Rifun, Somac, Ulcotenal, Zurcal, Zurcale, Zurcazol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 15/04/2010, Last updated: 17/01/2012 -
List item
Orphan designation: recombinant human interleukin-3 truncated diphtheria toxin fusion protein for: Treatment of acute myeloid leukaemia
Date of designation: 09/10/2015, Positive, Last updated: 25/04/2022 -
List item
Orphan designation: Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein for: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Date of designation: 09/08/2012, Positive, Last updated: 04/02/2022 -
List item
Orphan designation: Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein for: Treatment of cutaneous T-cell lymphoma
Date of designation: 09/08/2012, Positive, Last updated: 04/02/2022 -
List item
Orphan designation: Human monoclonal antibody targeting Staphylococcus aureus alpha-toxin (tosatoxumab) for: Treatment of pneumonia caused by Staphylococcus aureus
Date of designation: 05/03/2012, Positive, Last updated: 13/07/2021monoclonale umano contro la tossina alfa di Staphylococcus aureus … -
List item
Orphan designation: recombinant human interleukin-3 truncated diphtheria toxin fusion protein for: Treatment of blastic plasmacytoid dendritic cell neoplasm
Date of designation: 11/11/2015, Positive, Last updated: 25/01/2021 -
List item
Orphan designation: Chimeric monoclonal antibody to shiga toxin 1 and 2 for: Treatment of shiga-toxin-producing bacterial infection
Date of designation: 26/08/2005, Positive, Last updated: 12/04/2019 -
List item
Orphan designation: Carboxypeptidase G2 (glucarpidase) for: Adjunctive treatment in patients at risk of methotrexate toxicity
Date of designation: 03/02/2003, Positive, Last updated: 20/01/2022 -
List item
Orphan designation: Recombinant modified ricin toxin A-chain subunit for: Prevention of ricin poisoning
Date of designation: 21/03/2018, Positive, Last updated: 08/06/2020Subunità della catena A della tossina della ricina modificata … -
List item
Orphan designation: Equine immunoglobulin F(ab')2 fragments targeting Shiga toxin for: Prevention of haemolytic uraemic syndrome
Date of designation: 25/05/2018, Positive, Last updated: 24/07/2018 -
List item
Orphan designation: N,N'-bis(2-mercaptoethyl)isophthalamide (emeramide) for: Treatment of mercury toxicity
Date of designation: 11/01/2012, Positive, Last updated: 16/08/2017 -
List item
Orphan designation: Emeramide for: Prevention of mercury toxicity
Date of designation: 20/04/2017, Positive, Last updated: 16/08/2017Emeramide Prevenzione della tossicità da mercurio Latvian Emeramīds … Emeramid Prevenzjoni ta’ tossiċità bil-merkurju Polish Emeramid … -
List item
Orphan designation: Erdosteine for: Treatment of mercury toxicity
Date of designation: 08/11/2012, Positive, Last updated: 13/12/2012Erdosteina Trattamento di tossicità del mercurio Latvian Erdosteīns … Maltese Erdosteine Kura ta’ tossiċità bil-merkurju Polish Erdosteina … -
List item
Orphan designation: Erdosteine for: Treatment of lead toxicity
Date of designation: 06/12/2012, Positive, Last updated: 25/01/2013Erdosteina Trattamento della tossicità del piombo Latvian Erdosteīns … Maltese Erdosteine Kura ta’ tossiċità biċ-ċomb Polish Erdosteina … -
List item
Orphan designation: Octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate for: Prevention of Pseudomonas aeruginosa infections in patients with cystic fibrosis
Date of designation: 11/12/2001, Withdrawn, Last updated: 15/05/2009 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
12th pharmacovigilance stakeholder forum
European Medicines Agency, London, UK, 24/09/2018, Last updated: 08/10/2018 -
List item
Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use'
Last updated: 12/09/2022 -
List item
Workshop for micro-, small- and medium-sized enterprises: statistical perspectives in regulatory clinical development programmes
European Medicines Agency, London, UK, 05/02/2016, Last updated: 14/11/2016 -
List item
European Medicines Agency information day on measuring the impact of pharmacovigilance activities
European Medicines Agency, London, UK, 14/11/2017, Last updated: 19/09/2017and Associations (EFPIA) Vickie Edwards QPPV and Head of … industry perspective Vickie Edwards, AbbVie, Inc. On … Co-chairs: June Raine, MHRA, and Vicki Edwards, AbbVie Inc. 10:40 … -
List item
European Medicines Agency excellence in pharmacovigilance: Clinical trials and post-marketing training course
European Medicines Agency, London, UK, from 13/10/2014 to 17/10/2014, Last updated: 13/06/2014Compliance Janssen-Cilag France Vicki Edwards QPPV and Head of … SAFETY UPDATE REPORTS (DSURs) Vicki Edwards, AbbVie Ltd, UK 13:45 … SAFETY UPDATE REPORTS (PSURs) Vicki Edwards, AbbVie Ltd, UK … -
List item
16th industry stakeholder platform - operation of European Union (EU) pharmacovigilance
Online, 09:00 - 13:15 Amsterdam time (CET), 17/11/2021, Last updated: 06/12/2021Köhler Wendy Booth EFPIA Vicki Edwards Guy Demol David … -
List item
Joint European Medicines Agency/Drug Information Association information day on risk management planning
European Medicines Agency, London, UK, 30/06/2015, Last updated: 09/06/2015Intelligence, AbbVie, UK Vicki Edwards QPPV and Head of … context - industry perspective Vicki Edwards, AbbVie, UK 12:30 … -
List item
Industry stakeholder webinar on the UK withdrawal from the European Union - End of transition period
Virtual meeting, 30/11/2020, Last updated: 11/12/2020